Elon Musk vs Sam Altman From OpenAI CoFounders to Bitter Rivals in HighStakes Trial Jim Cramer Warns Rising Bond Yields Could Derail Stock Market Rally and Delay Rate Cuts TrumpXi Summit Concludes in Beijing Setting Stage for USChina Trade Talks Acco Brands ACCO Drops 293 Key Support at 362 20260515 Flex FLEX Q1 2026 Beat Revenue NA EPS Exceeds by Significant Cramer Backs Nvidias AI Chip Sales to China Says Stock Can Thrive Either Way Is 10x Genomics TXG Still a Buy After 118 Rally 20260518 Werewolf Therapeutics HOWL Stock Down 384 Support Test at 047 20260518 Amgen Announces CFO Peter Griffiths Retirement Succession Planning Underway Trainline Lifts Guidance Again Amid Strong Rail Ticket Sales MAS Overhauls Complex Product Rules as Retail Investors Gain Sophistication Intuitive Surgical Unveils New Innovations Aimed at Advancing Quintuple Aim Manufacturing Unicorn Raises 110M from Sequoia Paradigm and Stripe CoFounders US Jobless Claims Drop to Lowest Level Since MidMay Signaling Resilient Labor Market Centrus Energy LEU Q1 2026 Earnings Strong EPS Beat Amidst Minimal Revenue Disclosure WILC Q4 2025 Earnings Strong EPS Performance Amid Quiet Quarter XP Q1 2026 Earnings EPS Misses Estimates as Stock Declines Amidst Margin Pressure ESOA Q1 2026 Earnings EPS Surges Past Estimates with 743 Surprise Annexon Inc ANNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline but No Revenue Yet Hallador Energy HNRG Surges 473 Breaking Above Key Resistance Zone Cheniere Energy Partners CQP Holds Near Support After Modest Decline Amid Energy Sector Volatility SonoTek Corporation SOTK Bounces on Support as Volume Picks Up Real Asset Acquisition Corp Warrants RAAQW Drift Lower as Trading Remains Subdued Seer Inc SEER Edges Higher as Biotech Stock Tests Key Resistance EYPT Q1 2026 Earnings WiderthanExpected Loss as PreCommercial Biotech Continues RD Investment Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges EDU Q1 2026 Earnings EPS Beats Estimates Despite Stock Decline ARHS Q1 2026 Earnings EPS Beats Expectations Stock Slips Slightly Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure Arteris Inc AIP Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment Fed Rate Cut Hopes Dim as Jobs Data Highlights Persistent CostofLiving Pressures HEI Q4 2025 Earnings EPS Beats Estimates Amid Mixed Market Signal FGBIP Preferred Stock Holds Steady at 2049 as Yield Attracts Income Seekers